YBX1 and prostate cancer: Oncogenic effects of YBX1 are found in GC (51), bladder cancer (100), glioblastoma (101), CRC (76, 102), cholangiocarcinoma (103), clear cell renal cell carcinoma (ccRCC) (104), prostate cancer (56), epithelial ovarian cancer (105) and cervical cancer (57), mainly owing to YBX1-RNA interactions that have stabilizing effects on target RNAs.